A retrospective study assessing the efficacy and safety of LCIG in a 'real world' tertiary care center setting in patients with and without (deep brain stimulation ) DBS.
Latest Information Update: 01 Nov 2021
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- 01 Nov 2021 New trial record
- 22 Sep 2021 Results presented at the 25th International Congress of Parkinson's Disease and Movement Disorders